SNCA and Parkinson disease: Existing studies have shown that intragenic hypomethylation of the SNCA gene (encoding α‐synuclein [SNCA]) promotes abnormal SNCA aggregation, which—in synergy with oxidative stress and mitochondrial dysfunction—accelerates PD pathology.